447 related articles for article (PubMed ID: 30677745)
1. Pregnant women with opioid use disorder and their infants in three state Medicaid programs in 2013-2016.
Clemans-Cope L; Lynch V; Howell E; Hill I; Holla N; Morgan J; Johnson P; Cross-Barnet C; Thompson JA
Drug Alcohol Depend; 2019 Feb; 195():156-163. PubMed ID: 30677745
[TBL] [Abstract][Full Text] [Related]
2. State Strategies to Address Opioid Use Disorder Among Pregnant and Postpartum Women and Infants Prenatally Exposed to Substances, Including Infants with Neonatal Abstinence Syndrome.
Kroelinger CD; Rice ME; Cox S; Hickner HR; Weber MK; Romero L; Ko JY; Addison D; Mueller T; Shapiro-Mendoza C; Fehrenbach SN; Honein MA; Barfield WD
MMWR Morb Mortal Wkly Rep; 2019 Sep; 68(36):777-783. PubMed ID: 31513558
[TBL] [Abstract][Full Text] [Related]
3. Trends of Neonatal Abstinence Syndrome Epidemic and Maternal Risk Factors in Florida.
Wang X; Zhu Y; Dave CV; Alrwisan AA; Voils SA; Winterstein AG
Pharmacotherapy; 2017 Jul; 37(7):806-813. PubMed ID: 28500694
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and treatment of substance use disorder among pregnant women in three state Medicaid programs from 2013 to 2016.
Lynch V; Clemans-Cope L; Howell E; Hill I
J Subst Abuse Treat; 2021 May; 124():108265. PubMed ID: 33771273
[TBL] [Abstract][Full Text] [Related]
5. Maternal Opioid Use Disorder and Neonatal Abstinence Syndrome Among Rural US Residents, 2007-2014.
Kozhimannil KB; Chantarat T; Ecklund AM; Henning-Smith C; Jones C
J Rural Health; 2019 Jan; 35(1):122-132. PubMed ID: 30370563
[TBL] [Abstract][Full Text] [Related]
6. The interaction of neonatal abstinence syndrome and opioid use disorder treatment availability for women insured by medicaid.
Reising VA; Horne A; Bennett AC
Public Health Nurs; 2021 Jan; 38(1):98-105. PubMed ID: 33025600
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of Maternal-Risk Factors Related to Neonatal Abstinence Syndrome in a Commercial Claims Database: 2011-2015.
Dave CV; Goodin A; Zhu Y; Winterstein A; Wang X; Alrwisan A; Hartzema A
Pharmacotherapy; 2019 Oct; 39(10):1005-1011. PubMed ID: 31361913
[TBL] [Abstract][Full Text] [Related]
8. Maternal and infant characteristics associated with maternal opioid overdose in the year following delivery.
Nielsen T; Bernson D; Terplan M; Wakeman SE; Yule AM; Mehta PK; Bharel M; Diop H; Taveras EM; Wilens TE; Schiff DM
Addiction; 2020 Feb; 115(2):291-301. PubMed ID: 31692133
[TBL] [Abstract][Full Text] [Related]
9. Prenatal Use of Medication for Opioid Use Disorder and Other Prescription Opioids in Cases of Neonatal Opioid Withdrawal Syndrome: North Carolina Medicaid, 2016-2018.
Austin AE; Bona VD; Cox ME; Proescholdbell S; Fliss MD; Naumann RB
Am J Public Health; 2021 Sep; 111(9):1682-1685. PubMed ID: 34383554
[No Abstract] [Full Text] [Related]
10. Impact of psychiatric medication co-exposure on Neonatal Abstinence Syndrome severity.
Wachman EM; Warden AH; Thomas Z; Thomas-Lewis JA; Shrestha H; Nikita FNU; Shaw D; Saia K; Schiff DM
Drug Alcohol Depend; 2018 Nov; 192():45-50. PubMed ID: 30205307
[TBL] [Abstract][Full Text] [Related]
11. Maternal Opioid Use Disorder and the Risk of Postneonatal Infant Mortality.
Grossarth S; Osmundson SS; Wiese AD; Phillips SE; Pham A; Leech AA; Patrick SW; Spieker AJ; Grijalva CG; Adgent MA
JAMA Pediatr; 2023 Jul; 177(7):675-683. PubMed ID: 37155175
[TBL] [Abstract][Full Text] [Related]
12. Mental Health of Mothers of Infants with Neonatal Abstinence Syndrome and Prenatal Opioid Exposure.
Faherty LJ; Matone M; Passarella M; Lorch S
Matern Child Health J; 2018 Jun; 22(6):841-848. PubMed ID: 29417369
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a Nurse-Led Program for Rural Pregnant Women With Opioid Use Disorder to Improve Maternal-Neonatal Outcomes.
Paterno MT; Jablonski L; Klepacki A; Friedmann PD
J Obstet Gynecol Neonatal Nurs; 2019 Sep; 48(5):495-506. PubMed ID: 31374181
[TBL] [Abstract][Full Text] [Related]
14. Hospital Care of Opioid-Exposed Newborns: Clinical and Psychosocial Challenges.
Goyal NK; McAllister J
J Hosp Med; 2020 Oct; 15(10):613-618. PubMed ID: 32118559
[TBL] [Abstract][Full Text] [Related]
15. Opioid Use Disorder and Perinatal Outcomes.
Piske M; Homayra F; Min JE; Zhou H; Marchand C; Mead A; Ng J; Woolner M; Nosyk B
Pediatrics; 2021 Oct; 148(4):. PubMed ID: 34479983
[TBL] [Abstract][Full Text] [Related]
16. Utilization of treatment by Medicaid enrollees with opioid use disorder and co-occurring substance use disorders.
O'Brien P; Henke RM; Schaefer MB; Lin J; Creedon TB
Drug Alcohol Depend; 2020 Dec; 217():108261. PubMed ID: 32979735
[TBL] [Abstract][Full Text] [Related]
17. Cigarette smoking in opioid-dependent pregnant women: neonatal and maternal outcomes.
Jones HE; Heil SH; Tuten M; Chisolm MS; Foster JM; O'Grady KE; Kaltenbach K
Drug Alcohol Depend; 2013 Aug; 131(3):271-7. PubMed ID: 23279924
[TBL] [Abstract][Full Text] [Related]
18. The impact of Medicaid expansion on postpartum health care utilization among pregnant women with opioid use disorder.
Patton BP; Krans EE; Kim JY; Jarlenski M
Subst Abus; 2019; 40(3):371-377. PubMed ID: 30908175
[No Abstract] [Full Text] [Related]
19. Medicaid Coverage of Methadone Maintenance and the Use of Opioid Agonist Therapy Among Pregnant Women in Specialty Treatment.
Bachhuber MA; Mehta PK; Faherty LJ; Saloner B
Med Care; 2017 Dec; 55(12):985-990. PubMed ID: 29135769
[TBL] [Abstract][Full Text] [Related]
20. Neonatal Opioid Withdrawal Syndrome.
Patrick SW; Barfield WD; Poindexter BB;
Pediatrics; 2020 Nov; 146(5):. PubMed ID: 33106341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
